| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 1.98e-04 | 21 | 20 | 2 | GO:0061676 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.05e-03 | 1244 | 20 | 6 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.17e-03 | 1271 | 20 | 6 | GO:0000987 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.02e-03 | 1412 | 20 | 6 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.39e-03 | 1459 | 20 | 6 | GO:0000977 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.24e-03 | 85 | 20 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | syntaxin binding | 3.39e-03 | 87 | 20 | 2 | GO:0019905 | |
| GeneOntologyMolecularFunction | microtubule binding | 3.41e-03 | 308 | 20 | 3 | GO:0008017 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 6.17e-06 | 34 | 22 | 3 | GO:0008356 | |
| GeneOntologyBiologicalProcess | Golgi organization | 2.77e-05 | 168 | 22 | 4 | GO:0007030 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 1.64e-04 | 18 | 22 | 2 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 1.84e-04 | 19 | 22 | 2 | GO:0060050 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 2.71e-04 | 23 | 22 | 2 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 2.96e-04 | 24 | 22 | 2 | GO:0060049 | |
| GeneOntologyBiologicalProcess | Golgi localization | 3.75e-04 | 27 | 22 | 2 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 4.04e-04 | 28 | 22 | 2 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 4.04e-04 | 28 | 22 | 2 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 4.04e-04 | 28 | 22 | 2 | GO:0048313 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 4.89e-04 | 354 | 22 | 4 | GO:0050769 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 6.69e-04 | 36 | 22 | 2 | GO:0010560 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 7.07e-04 | 37 | 22 | 2 | GO:0000212 | |
| GeneOntologyBiologicalProcess | cell division | 7.09e-04 | 697 | 22 | 5 | GO:0051301 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 8.27e-04 | 40 | 22 | 2 | GO:1903020 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 9.10e-04 | 418 | 22 | 4 | GO:0051962 | |
| GeneOntologyBiologicalProcess | stem cell division | 1.24e-03 | 49 | 22 | 2 | GO:0017145 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 1.67e-03 | 57 | 22 | 2 | GO:0007020 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.69e-03 | 494 | 22 | 4 | GO:0031346 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 4.46e-08 | 33 | 23 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | cis-Golgi network | 2.13e-06 | 85 | 23 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 3.18e-06 | 94 | 23 | 4 | GO:0032580 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.34e-05 | 135 | 23 | 4 | GO:0031985 | |
| GeneOntologyCellularComponent | Golgi stack | 3.39e-05 | 171 | 23 | 4 | GO:0005795 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.28e-03 | 443 | 23 | 4 | GO:0098791 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.35e-03 | 201 | 23 | 3 | GO:0072686 | |
| GeneOntologyCellularComponent | spindle pole | 1.42e-03 | 205 | 23 | 3 | GO:0000922 | |
| MousePheno | abnormal skeletal muscle satellite cell proliferation | 3.43e-05 | 8 | 16 | 2 | MP:0009410 | |
| MousePheno | increased alveolar macrophage number | 1.11e-04 | 14 | 16 | 2 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 1.28e-04 | 15 | 16 | 2 | MP:0014227 | |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 1.60e-04 | 95 | 16 | 3 | MP:0009832 | |
| MousePheno | abnormal Golgi vesicle transport | 2.80e-04 | 22 | 16 | 2 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 3.34e-04 | 24 | 16 | 2 | MP:0031355 | |
| MousePheno | abnormal alveolar macrophage morphology | 4.24e-04 | 27 | 16 | 2 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 4.56e-04 | 28 | 16 | 2 | MP:0009833 | |
| MousePheno | abnormal sperm midpiece morphology | 5.43e-04 | 144 | 16 | 3 | MP:0009831 | |
| MousePheno | absent acrosome | 5.97e-04 | 32 | 16 | 2 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 6.35e-04 | 33 | 16 | 2 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 6.74e-04 | 34 | 16 | 2 | MP:0020849 | |
| MousePheno | decreased neuron number | 7.25e-04 | 376 | 16 | 4 | MP:0008948 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 1.23e-03 | 46 | 16 | 2 | MP:0020850 | |
| MousePheno | abnormal skeletal muscle regeneration | 1.34e-03 | 48 | 16 | 2 | MP:0013237 | |
| MousePheno | abnormal neuron number | 1.49e-03 | 456 | 16 | 4 | MP:0008946 | |
| MousePheno | abnormal Purkinje cell morphology | 1.49e-03 | 204 | 16 | 3 | MP:0000877 | |
| MousePheno | pulmonary fibrosis | 1.52e-03 | 51 | 16 | 2 | MP:0006050 | |
| MousePheno | increased spleen red pulp amount | 1.58e-03 | 52 | 16 | 2 | MP:0008476 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 1.85e-03 | 220 | 16 | 3 | MP:0000875 | |
| MousePheno | abnormal surfactant physiology | 1.96e-03 | 58 | 16 | 2 | MP:0004782 | |
| MousePheno | immotile sperm | 2.02e-03 | 59 | 16 | 2 | MP:0020869 | |
| MousePheno | abnormal liver lobule morphology | 2.08e-03 | 229 | 16 | 3 | MP:0008987 | |
| MousePheno | abnormal respiratory epithelium morphology | 2.23e-03 | 235 | 16 | 3 | MP:0010942 | |
| MousePheno | abnormal muscle regeneration | 2.38e-03 | 64 | 16 | 2 | MP:0000750 | |
| MousePheno | postnatal growth retardation | 2.39e-03 | 881 | 16 | 5 | MP:0001732 | |
| MousePheno | abnormal liver parenchyma morphology | 2.46e-03 | 243 | 16 | 3 | MP:0008986 | |
| MousePheno | abnormal male reproductive system physiology | 2.53e-03 | 1329 | 16 | 6 | MP:0003698 | |
| MousePheno | abnormal type II pneumocyte morphology | 2.60e-03 | 67 | 16 | 2 | MP:0002275 | |
| MousePheno | decreased Purkinje cell number | 2.60e-03 | 67 | 16 | 2 | MP:0000880 | |
| MousePheno | abnormal postnatal growth | 2.72e-03 | 907 | 16 | 5 | MP:0001731 | |
| MousePheno | abnormal Purkinje cell number | 2.76e-03 | 69 | 16 | 2 | MP:0000878 | |
| MousePheno | abnormal cerebellar layer morphology | 3.08e-03 | 263 | 16 | 3 | MP:0009956 | |
| MousePheno | abnormal sperm nucleus morphology | 3.16e-03 | 74 | 16 | 2 | MP:0009232 | |
| MousePheno | globozoospermia | 3.16e-03 | 74 | 16 | 2 | MP:0002686 | |
| MousePheno | male infertility | 3.24e-03 | 944 | 16 | 5 | MP:0001925 | |
| MousePheno | abnormal cell cytoskeleton morphology | 3.25e-03 | 75 | 16 | 2 | MP:0020378 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 3.42e-03 | 77 | 16 | 2 | MP:0002273 | |
| MousePheno | liver fibrosis | 3.42e-03 | 77 | 16 | 2 | MP:0003333 | |
| Domain | Golgin_A | 9.89e-07 | 18 | 21 | 3 | IPR024858 | |
| Domain | GOLGA2L5 | 9.89e-07 | 18 | 21 | 3 | PF15070 | |
| Domain | LMSTEN | 1.20e-06 | 2 | 21 | 2 | PF07988 | |
| Domain | Tscrpt_reg_Wos2-domain | 1.20e-06 | 2 | 21 | 2 | IPR012642 | |
| Domain | C-myb_C | 3.61e-06 | 3 | 21 | 2 | IPR015395 | |
| Domain | Cmyb_C | 3.61e-06 | 3 | 21 | 2 | PF09316 | |
| Domain | HTH_MYB | 4.31e-05 | 9 | 21 | 2 | PS51294 | |
| Domain | Myb_dom | 4.31e-05 | 9 | 21 | 2 | IPR017930 | |
| Domain | SRCR | 2.50e-04 | 21 | 21 | 2 | PF00530 | |
| Domain | SR | 3.56e-04 | 25 | 21 | 2 | SM00202 | |
| Domain | - | 3.56e-04 | 25 | 21 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 3.85e-04 | 26 | 21 | 2 | PS00420 | |
| Domain | SRCR_2 | 3.85e-04 | 26 | 21 | 2 | PS50287 | |
| Domain | SRCR-like_dom | 3.85e-04 | 26 | 21 | 2 | IPR017448 | |
| Domain | SRCR | 4.16e-04 | 27 | 21 | 2 | IPR001190 | |
| Domain | Myb_DNA-binding | 7.01e-04 | 35 | 21 | 2 | PF00249 | |
| Domain | MYB_LIKE | 8.26e-04 | 38 | 21 | 2 | PS50090 | |
| Domain | SANT | 1.43e-03 | 50 | 21 | 2 | SM00717 | |
| Domain | SANT/Myb | 1.54e-03 | 52 | 21 | 2 | IPR001005 | |
| Domain | - | 3.74e-03 | 283 | 21 | 3 | 1.10.10.60 | |
| Domain | Homeodomain-like | 5.84e-03 | 332 | 21 | 3 | IPR009057 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 3.05e-06 | 23 | 18 | 3 | M39883 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 5.43e-05 | 59 | 18 | 3 | M48104 | |
| Pathway | REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER | 2.07e-04 | 17 | 18 | 2 | M48248 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 3.83e-04 | 23 | 18 | 2 | MM14620 | |
| Pubmed | Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements. | 4.18e-07 | 2 | 23 | 2 | 38368814 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 31563982 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 8570177 | ||
| Pubmed | Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases. | 4.18e-07 | 2 | 23 | 2 | 36074655 | |
| Pubmed | Arrest of spermatogenesis and defective breast development in mice lacking A-myb. | 4.18e-07 | 2 | 23 | 2 | 9109487 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 29410490 | ||
| Pubmed | A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. | 4.18e-07 | 2 | 23 | 2 | 31595312 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 11124526 | ||
| Pubmed | DNA binding and transactivation activity of A-myb, a c-myb-related gene. | 4.18e-07 | 2 | 23 | 2 | 7987850 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 31028361 | ||
| Pubmed | The myb gene family in cell growth, differentiation and apoptosis. | 1.25e-06 | 3 | 23 | 2 | 10378697 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 29149504 | ||
| Pubmed | Nucleolin, a novel partner for the Myb transcription factor family that regulates their activity. | 1.25e-06 | 3 | 23 | 2 | 10660576 | |
| Pubmed | Temporal patterns of A-myb and B-myb gene expression during testis development. | 2.51e-06 | 4 | 23 | 2 | 8808690 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 16055500 | ||
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 3.25e-05 | 13 | 23 | 2 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 3.25e-05 | 13 | 23 | 2 | 32873390 | |
| Pubmed | 3.25e-05 | 13 | 23 | 2 | 21552007 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 3.25e-05 | 13 | 23 | 2 | 29128360 | |
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 3.25e-05 | 13 | 23 | 2 | 28055014 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 3.25e-05 | 13 | 23 | 2 | 28028212 | |
| Pubmed | 3.79e-05 | 14 | 23 | 2 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 3.79e-05 | 14 | 23 | 2 | 27226319 | |
| Pubmed | 3.79e-05 | 14 | 23 | 2 | 37831422 | ||
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 3.79e-05 | 14 | 23 | 2 | 33543287 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 4.37e-05 | 15 | 23 | 2 | 17046993 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 4.37e-05 | 15 | 23 | 2 | 26165940 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 4.37e-05 | 15 | 23 | 2 | 17189423 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 4.37e-05 | 15 | 23 | 2 | 17204322 | |
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 26083584 | ||
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 16413118 | ||
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 37635409 | ||
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 4.37e-05 | 15 | 23 | 2 | 23185636 | |
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 4.37e-05 | 15 | 23 | 2 | 28509431 | |
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 16399995 | ||
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 16336229 | ||
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 18166528 | ||
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 4.99e-05 | 16 | 23 | 2 | 21640725 | |
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 5.66e-05 | 17 | 23 | 2 | 14718562 | |
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 27655914 | ||
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 14728599 | ||
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 28717168 | ||
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 20004763 | ||
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 21147753 | ||
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 15800058 | ||
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 24227724 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 6.36e-05 | 18 | 23 | 2 | 20230794 | |
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 22718342 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 6.36e-05 | 18 | 23 | 2 | 24367100 | |
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 20943658 | ||
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 25208654 | ||
| Pubmed | 7.10e-05 | 19 | 23 | 2 | 23444373 | ||
| Pubmed | 7.10e-05 | 19 | 23 | 2 | 12646573 | ||
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 7.10e-05 | 19 | 23 | 2 | 34255394 | |
| Pubmed | 7.10e-05 | 19 | 23 | 2 | 15452145 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 7.10e-05 | 19 | 23 | 2 | 14622145 | |
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 7.10e-05 | 19 | 23 | 2 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 7.10e-05 | 19 | 23 | 2 | 17664336 | |
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 7.10e-05 | 19 | 23 | 2 | 38048369 | |
| Pubmed | 7.10e-05 | 19 | 23 | 2 | 17724343 | ||
| Pubmed | 7.10e-05 | 19 | 23 | 2 | 22841714 | ||
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 7.10e-05 | 19 | 23 | 2 | 17003038 | |
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 7.10e-05 | 19 | 23 | 2 | 34042944 | |
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 7.89e-05 | 20 | 23 | 2 | 21300694 | |
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 7.89e-05 | 20 | 23 | 2 | 20368623 | |
| Pubmed | 7.89e-05 | 20 | 23 | 2 | 23918928 | ||
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 7.89e-05 | 20 | 23 | 2 | 31949138 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 7.89e-05 | 20 | 23 | 2 | 17359961 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 7.89e-05 | 20 | 23 | 2 | 34128978 | |
| Pubmed | 7.89e-05 | 20 | 23 | 2 | 30236446 | ||
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 7.89e-05 | 20 | 23 | 2 | 29437892 | |
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 8.72e-05 | 21 | 23 | 2 | 19061864 | |
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 15229288 | ||
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 8.72e-05 | 21 | 23 | 2 | 27118846 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 8.72e-05 | 21 | 23 | 2 | 22216013 | |
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 8.72e-05 | 21 | 23 | 2 | 20003423 | |
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 23386608 | ||
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 21645620 | ||
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 36292593 | ||
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 9.59e-05 | 22 | 23 | 2 | 36656123 | |
| Pubmed | 9.59e-05 | 22 | 23 | 2 | 34897463 | ||
| Pubmed | 1.05e-04 | 23 | 23 | 2 | 25636444 | ||
| Pubmed | 1.05e-04 | 23 | 23 | 2 | 37848288 | ||
| Pubmed | 1.05e-04 | 23 | 23 | 2 | 18662990 | ||
| Pubmed | Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. | 1.05e-04 | 23 | 23 | 2 | 21111240 | |
| Pubmed | 1.05e-04 | 23 | 23 | 2 | 18001291 | ||
| Pubmed | Pofut1 is required for the proper localization of the Notch receptor during mouse development. | 1.05e-04 | 23 | 23 | 2 | 18547789 | |
| Pubmed | 1.14e-04 | 24 | 23 | 2 | 24161848 | ||
| Pubmed | 1.14e-04 | 24 | 23 | 2 | 38814743 | ||
| Pubmed | The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. | 1.14e-04 | 24 | 23 | 2 | 20223754 | |
| Pubmed | 1.14e-04 | 24 | 23 | 2 | 26060116 | ||
| Pubmed | Dual role for CXCL12 signaling in semilunar valve development. | 1.14e-04 | 24 | 23 | 2 | 34433040 | |
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 1.14e-04 | 24 | 23 | 2 | 18434600 | |
| Pubmed | 1.14e-04 | 24 | 23 | 2 | 21187406 | ||
| Pubmed | Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. | 1.14e-04 | 24 | 23 | 2 | 22364862 | |
| Pubmed | 1.24e-04 | 25 | 23 | 2 | 26582200 | ||
| Pubmed | Nubp1 is required for lung branching morphogenesis and distal progenitor cell survival in mice. | 1.24e-04 | 25 | 23 | 2 | 23028652 | |
| Pubmed | A set of anonymous DNA clones as markers for mouse gene mapping. | 1.24e-04 | 25 | 23 | 2 | 1351769 | |
| Pubmed | 1.24e-04 | 25 | 23 | 2 | 29587143 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 1.45e-09 | 100 | 23 | 5 | chr15q13 | |
| Cytoband | 15q13.2 | 5.01e-05 | 21 | 23 | 2 | 15q13.2 | |
| Cytoband | 15q13.3 | 7.75e-05 | 26 | 23 | 2 | 15q13.3 | |
| Cytoband | 12p13.3 | 1.04e-04 | 30 | 23 | 2 | 12p13.3 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.93e-04 | 27 | 14 | 2 | 1253 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 7.50e-04 | 53 | 14 | 2 | 532 | |
| Coexpression | LI_ESTROGENE_META_E2_RESPONSE_UP | 2.49e-05 | 65 | 23 | 3 | M48211 | |
| Coexpression | LI_ESTROGENE_EARLY_E2_RESPONSE_UP | 6.17e-05 | 88 | 23 | 3 | M48213 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.08e-08 | 199 | 23 | 5 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.08e-08 | 199 | 23 | 5 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.08e-08 | 199 | 23 | 5 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.08e-08 | 199 | 23 | 5 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.51e-06 | 189 | 23 | 4 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 189 | 23 | 4 | b8cbfc47f3f40b6fccd15899d58c87d07b0001aa | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 190 | 23 | 4 | e0b363f772817cfc6ab425430805c1cddcba23f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-06 | 194 | 23 | 4 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 196 | 23 | 4 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-06 | 197 | 23 | 4 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-06 | 198 | 23 | 4 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.14e-06 | 200 | 23 | 4 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.31e-05 | 143 | 23 | 3 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | COVID-19_Severe-MAIT|World / disease group, cell group and cell class | 5.54e-05 | 145 | 23 | 3 | 8d63f97812f63329ef9c940b291dc5a1c4d90690 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.54e-05 | 145 | 23 | 3 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.00e-05 | 149 | 23 | 3 | 95b21d67d6c335330a508f78d5cc074fdaf92275 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 6.13e-05 | 150 | 23 | 3 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 8.27e-05 | 166 | 23 | 3 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-05 | 166 | 23 | 3 | e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-05 | 168 | 23 | 3 | 26fce414439ccd204e3acb41f2b4f75072df5a26 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-05 | 168 | 23 | 3 | 61a5435b27b01ff1a509ea463a6af220c5d2c9b3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-CMP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.57e-05 | 168 | 23 | 3 | 9fc9c93ab7513bf4dfefc866b97c703208a238c9 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 8.88e-05 | 170 | 23 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 177 | 23 | 3 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.00e-04 | 177 | 23 | 3 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-04 | 177 | 23 | 3 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-04 | 177 | 23 | 3 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.00e-04 | 177 | 23 | 3 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Natural_Killer_Cell|Trachea / Age, Tissue, Lineage and Cell class | 1.02e-04 | 178 | 23 | 3 | d2e1f6b7933b7da2682393e5ff5e03cdd8f64761 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 182 | 23 | 3 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.12e-04 | 184 | 23 | 3 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-04 | 185 | 23 | 3 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 185 | 23 | 3 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 1.18e-04 | 187 | 23 | 3 | 0e7aa481effdd8c2fbdf8b65852821dec2d92cde | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 187 | 23 | 3 | 23be50d81f4404a609dea821e1a66d221c0e0615 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-04 | 187 | 23 | 3 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 188 | 23 | 3 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 189 | 23 | 3 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 190 | 23 | 3 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 190 | 23 | 3 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-04 | 190 | 23 | 3 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-04 | 190 | 23 | 3 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 190 | 23 | 3 | 081b7bc07b6e5685e8a91b9ae6c1141623723700 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 190 | 23 | 3 | 773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 1.25e-04 | 191 | 23 | 3 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-04 | 191 | 23 | 3 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 191 | 23 | 3 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 191 | 23 | 3 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.25e-04 | 191 | 23 | 3 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 191 | 23 | 3 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 191 | 23 | 3 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 191 | 23 | 3 | bce138f067b8962ecef1ddec6511a3f142d81d78 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.27e-04 | 192 | 23 | 3 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 192 | 23 | 3 | 7e7383093efaadceadd4d1f900c2d39cd690102e | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 1.27e-04 | 192 | 23 | 3 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 192 | 23 | 3 | 4e3deefd30adb7bf1eba294610eed3d077aa9418 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-04 | 193 | 23 | 3 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.29e-04 | 193 | 23 | 3 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.29e-04 | 193 | 23 | 3 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 193 | 23 | 3 | c9e3fefa8d68d0e2b954f85ce37813185ff98d84 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.29e-04 | 193 | 23 | 3 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.29e-04 | 193 | 23 | 3 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.29e-04 | 193 | 23 | 3 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 23 | 3 | ef30baa19b7aa97b61dea916fc2e0f5cf49848d6 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 194 | 23 | 3 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.31e-04 | 194 | 23 | 3 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 194 | 23 | 3 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-04 | 194 | 23 | 3 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 194 | 23 | 3 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 194 | 23 | 3 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 23 | 3 | 260649f5c4aeaa9cbf5ed5ae5e9f293d75bb0457 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 194 | 23 | 3 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 23 | 3 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 1.31e-04 | 194 | 23 | 3 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 23 | 3 | a062100ea6cd512a108f9036c259e0cd0f458563 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 195 | 23 | 3 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 1.33e-04 | 195 | 23 | 3 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | IPF-Myeloid|IPF / Disease state, Lineage and Cell class | 1.33e-04 | 195 | 23 | 3 | fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 195 | 23 | 3 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.33e-04 | 195 | 23 | 3 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | IPF-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.33e-04 | 195 | 23 | 3 | 50edda117b438b9c3616191884007466f6d974f0 | |
| ToppCell | Healthy_Control-Myeloid-mDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.33e-04 | 195 | 23 | 3 | d9a6fc7fa0047472821e1dcf0962ccb3f061313e | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.33e-04 | 195 | 23 | 3 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 195 | 23 | 3 | 518cc3baeb7cf2ad068692cbe85fd75be67f1872 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 195 | 23 | 3 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 195 | 23 | 3 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 195 | 23 | 3 | c707885d092aedbbe14f51f7de4a5911c9214289 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-04 | 195 | 23 | 3 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 195 | 23 | 3 | 799992721369357484300fe218aff075154c3148 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 195 | 23 | 3 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 195 | 23 | 3 | e8fb552f9ab77b656c27abc66af523b56cd9f9ad | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 195 | 23 | 3 | 5f46f9aca1c7f76416e861aa94d24fc1d6266113 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.33e-04 | 195 | 23 | 3 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 195 | 23 | 3 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | Healthy_Control-Myeloid-mDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.33e-04 | 195 | 23 | 3 | 32f505b2c24f4386367706b775e79271f99156f2 | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.35e-04 | 196 | 23 | 3 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 1.35e-04 | 196 | 23 | 3 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 196 | 23 | 3 | 3fd5567ea14193181929134c377e8a38fb4f47fd | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 196 | 23 | 3 | ce3709adbde7559b40c964888935914f66003247 | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.73e-05 | 182 | 20 | 4 | 1663_DN | |
| Disease | kallikrein-7 measurement | 3.92e-06 | 5 | 19 | 2 | EFO_0008195 | |
| Disease | adult T-cell leukemia/lymphoma (is_marker_for) | 1.41e-05 | 9 | 19 | 2 | DOID:0050523 (is_marker_for) | |
| Disease | L lactate dehydrogenase measurement | 1.26e-04 | 26 | 19 | 2 | EFO_0004808 | |
| Disease | orofacial cleft | 2.58e-04 | 37 | 19 | 2 | MONDO_0000358 | |
| Disease | creatine kinase measurement | 6.58e-04 | 59 | 19 | 2 | EFO_0004534 | |
| Disease | Malignant Glioma | 9.24e-04 | 70 | 19 | 2 | C0555198 | |
| Disease | mixed gliomas | 9.24e-04 | 70 | 19 | 2 | C0259783 | |
| Disease | Glioma | 1.42e-03 | 87 | 19 | 2 | C0017638 | |
| Disease | Adenoid Cystic Carcinoma | 1.87e-03 | 100 | 19 | 2 | C0010606 | |
| Disease | R-6-hydroxywarfarin measurement | 2.42e-03 | 114 | 19 | 2 | EFO_0803327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HWRGEALREKLRHRE | 2231 | Q7Z7A1 | |
| RDHIKDEWEGLRKHD | 546 | O60306 | |
| EGRALLHWACDRGHK | 191 | Q9BR61 | |
| PSRGWGQHDCRHKED | 1116 | Q9NR16 | |
| HELEHRWRGGCEERK | 771 | Q68DA7 | |
| WEIRDRLLKDGHCDR | 131 | P23759 | |
| ELGRDGIRWEAEAHH | 296 | P0C5J1 | |
| ALRCDGETDKHWRHR | 21 | Q9NXV6 | |
| CAEHIEGERARWHQR | 241 | H3BV12 | |
| HLKGRIGKQCRERWH | 121 | P10242 | |
| FEDCRTGAWRHGRIH | 421 | P18507 | |
| RFGSERDWVGLHCEH | 101 | Q8N100 | |
| CAEHIEGERARWHQR | 241 | I6L899 | |
| CAEHIEGERARWHQR | 241 | A6NCC3 | |
| RRWGHSECGHKEDAA | 1011 | Q86VB7 | |
| HLKGRIGKQCRERWH | 116 | P10243 | |
| GHCIHERWKCDGEEE | 96 | Q14114 | |
| EWDLGVCRESVHRKG | 191 | O75677 | |
| LHLRKRWKREECEGH | 111 | Q14586 | |
| GRHDWRHKEDAGVFC | 641 | Q4G0T1 | |
| DLEHWHGRKTDDLGR | 236 | O43247 | |
| HGEVGEHKDRIERQW | 231 | O15535 | |
| GKDWKEDEHCLRRLI | 541 | B1ANS9 | |
| CAEHIEGERARWHQR | 241 | F8WBI6 |